Legal & General Group’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$802K Buy
86,972
+13,886
+19% +$128K ﹤0.01% 2297
2025
Q1
$627K Buy
73,086
+65,781
+900% +$564K ﹤0.01% 2332
2024
Q4
$78.5K Sell
7,305
-67
-0.9% -$720 ﹤0.01% 2741
2024
Q3
$41.9K Buy
7,372
+772
+12% +$4.39K ﹤0.01% 2818
2024
Q2
$27.9K Sell
6,600
-64,487
-91% -$272K ﹤0.01% 2895
2024
Q1
$362K Sell
71,087
-186
-0.3% -$947 ﹤0.01% 2552
2023
Q4
$664K Sell
71,273
-201
-0.3% -$1.87K ﹤0.01% 2352
2023
Q3
$468K Buy
71,474
+828
+1% +$5.42K ﹤0.01% 2467
2023
Q2
$574K Buy
70,646
+32,706
+86% +$266K ﹤0.01% 2419
2023
Q1
$325K Buy
37,940
+1,790
+5% +$15.3K ﹤0.01% 2433
2022
Q4
$335K Buy
36,150
+1,111
+3% +$10.3K ﹤0.01% 2431
2022
Q3
$362K Buy
35,039
+1,483
+4% +$15.3K ﹤0.01% 2424
2022
Q2
$336K Buy
33,556
+1,737
+5% +$17.4K ﹤0.01% 2455
2022
Q1
$392K Buy
31,819
+612
+2% +$7.54K ﹤0.01% 2459
2021
Q4
$541K Buy
31,207
+1,201
+4% +$20.8K ﹤0.01% 2386
2021
Q3
$538K Buy
30,006
+19,940
+198% +$358K ﹤0.01% 2395
2021
Q2
$231K Buy
10,066
+3,658
+57% +$83.9K ﹤0.01% 2499
2021
Q1
$96K Buy
6,408
+158
+3% +$2.37K ﹤0.01% 2633
2020
Q4
$34K Sell
6,250
-167
-3% -$908 ﹤0.01% 2902
2020
Q3
$29K Sell
6,417
-1,891
-23% -$8.55K ﹤0.01% 2853
2020
Q2
$41K Buy
8,308
+388
+5% +$1.92K ﹤0.01% 2779
2020
Q1
$25K Sell
7,920
-768
-9% -$2.42K ﹤0.01% 2823
2019
Q4
$22K Buy
8,688
+1,520
+21% +$3.85K ﹤0.01% 3149
2019
Q3
$23K Hold
7,168
﹤0.01% 3080
2019
Q2
$24K Buy
+7,168
New +$24K ﹤0.01% 3120
2018
Q2
Sell
-5,773
Closed -$16K 3355
2018
Q1
$16K Hold
5,773
﹤0.01% 3145
2017
Q4
$19K Sell
5,773
-2,439
-30% -$8.03K ﹤0.01% 3150
2017
Q3
$34K Buy
8,212
+3,652
+80% +$15.1K ﹤0.01% 3031
2017
Q2
$24K Hold
4,560
﹤0.01% 3112
2017
Q1
$26K Sell
4,560
-1,388
-23% -$7.91K ﹤0.01% 3011
2016
Q4
$24K Buy
+5,948
New +$24K ﹤0.01% 3087